Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502) - Sinicrope, F A; Ou, F-S; Zemla, T (J Clin Oncol, 2019)